The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of camrelizumab combined with chemotherapy (irinotecan combined with platinum) followed by camrelizumab combined with apatinib in the first-line treatment of advanced small cell lung cancer: A phase II study.
 
Jun Ni
No Relationships to Disclose
 
Xiaotong Zhang
No Relationships to Disclose
 
Ruili Pan
No Relationships to Disclose
 
Hanping Wang
No Relationships to Disclose
 
Xiaoyan Si
No Relationships to Disclose
 
Xiaoxia Cui
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose